{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:30:17Z","timestamp":1784763017001,"version":"3.55.0"},"reference-count":31,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T00:00:00Z","timestamp":1648944000000},"content-version":"unspecified","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,2,25]]},"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the feasibility of three-vessel three-dimensional (3D) quantitative coronary angiography (QCA)-based fractional flow reserve (FFR) computation in patients discussed within the Heart Team in whom the treatment decision was based on angiography alone, and to evaluate the concordance between 3D QCA-based vessel FFR (vFFR)-confirmed functional lesion significance and revascularisation strategy as proposed by the Heart Team.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective, cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>3D QCA-based FFR indices have not yet been evaluated in the context of Heart Team decision-making; consecutive patients from six institutions were screened for eligibility and three-vessel vFFR was computed by blinded analysts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Consecutive patients with chronic coronary syndrome or unstable angina referred for Heart Team consultation. Exclusion criteria involved: presentation with acute myocardial infarction (MI), significant valve disease, left ventricle ejection fraction &lt;30%, inadequate quality of angiogram precluding vFFR computation in all three epicardial coronary arteries (ie, absence of a minimum of two angiographic projections with views of at least 30\u00b0 apart, substantial foreshortening\/overlap of the vessel, poor contrast medium injection, ostial lesions, chronic total occlusions).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>Discordance between vFFR-confirmed lesion significance and revascularisation was assessed as the primary outcome measure. Rates of major adverse cardiac events (MACE) defined as cardiac death, MI and clinically driven revascularisation were reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of a total of 1003 patients were screened for eligibility, 416 patients (age 65.6\u00b110.6, 71.2% male, 53% stable angina) were included. The most important reason for screening failure was insufficient quality of the angiogram (43%). Discordance between vFFR confirmed lesion significance and revascularisation was found in 124\/416 patients (29.8%) corresponding to 149 vessels (46\/149 vessels (30.9%) were reclassified as significant and 103\/149 vessels (69.1%) as non-significant by vFFR). Over a median of 962 days, the cumulative incidence of MACE was 29.7% versus 18.5% in discordant versus concordant patients (p=0.031).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>vFFR computation is feasible in around 40% of the patients referred for Heart Team discussion, a limitation that is mostly based on insufficient quality of the angiogram. Three vessel vFFR screening indicated discordance between vFFR confirmed lesion significance and revascularisation in 29.8% of the patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-054202","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T12:13:40Z","timestamp":1649074420000},"page":"e054202","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Three-dimensional QCA-based vessel fractional flow reserve (vFFR) in Heart Team decision-making: a multicentre, retrospective, cohort study"],"prefix":"10.1136","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct03791320","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03791320","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03729739","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04931771","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04931771","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0966-3313","authenticated-orcid":false,"given":"Mariusz","family":"Tomaniak","sequence":"first","affiliation":[{"name":"Department of Cardiology, Erasmus University Medical Center, Thorax Center, Rotterdam, the Netherlands"},{"name":"First Department of Cardiology, Medical University of Warsaw, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaneshka","family":"Masdjedi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus University Medical Center, Thorax Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Neleman","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus University Medical Center, Thorax Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim T","family":"Kucuk","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus University Medical Center, Thorax Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alise","family":"Vermaire","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus University Medical Center, Thorax Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurens J C","family":"van Zandvoort","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus University Medical Center, Thorax Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Van Boven","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus University Medical Center, Thorax Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas M","family":"van Dalen","sequence":"additional","affiliation":[{"name":"Sint Franciscus Gasthuis & Vlietland Hospital, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loe Kie","family":"Soei","sequence":"additional","affiliation":[{"name":"Sint Franciscus Gasthuis & Vlietland Hospital, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wijnand K","family":"den Dekker","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus University Medical Center, Thorax Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Kardys","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus University Medical Center, Thorax Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen M","family":"Wilschut","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus University Medical Center, Thorax Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Diletti","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus University Medical Center, Thorax Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Zijlstra","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus University Medical Center, Thorax Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas M","family":"Van Mieghem","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus University Medical Center, Thorax Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8628-1410","authenticated-orcid":false,"given":"Joost","family":"Daemen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus University Medical Center, Thorax Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,4,4]]},"reference":[{"key":"2025121402530570000_12.4.e054202.1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv452"},{"key":"2025121402530570000_12.4.e054202.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205361"},{"key":"2025121402530570000_12.4.e054202.3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy394"},{"key":"2025121402530570000_12.4.e054202.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2017.11.030"},{"key":"2025121402530570000_12.4.e054202.5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.006646"},{"key":"2025121402530570000_12.4.e054202.6","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.003288","article-title":"Impact of routine fractional flow reserve evaluation during coronary angiography on management strategy and clinical outcome: one-year results of the POST-IT","volume":"9","author":"Baptista","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"2025121402530570000_12.4.e054202.7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.113.000978"},{"key":"2025121402530570000_12.4.e054202.8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu338"},{"key":"2025121402530570000_12.4.e054202.9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht059"},{"key":"2025121402530570000_12.4.e054202.10","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehy445","article-title":"Diagnostic performance of angiography-derived fractional flow reserve: a systematic review and Bayesian meta-analysis","volume":"39","author":"Collet","year":"2018","journal-title":"Eur Heart J"},{"key":"2025121402530570000_12.4.e054202.11","unstructured":"Masdjedi K , van Zandvoort LJC , Balbi MM . Validation of 3-Dimensional Quantitative Coronary Angiography based software to calculate Fractional Flow Reserve: Fast Assessment of STenosis severity (FAST)-study. EuroIntervention 2019."},{"key":"2025121402530570000_12.4.e054202.12","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007107","article-title":"Evaluation of coronary artery stenosis by quantitative flow ratio during invasive coronary angiography: the WIFI II study (Wire-Free functional imaging II)","volume":"11","author":"Westra","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025121402530570000_12.4.e054202.13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009603","article-title":"Diagnostic performance of In-Procedure Angiography-Derived quantitative flow reserve compared to Pressure-Derived fractional flow reserve: the favor II Europe-Japan study","volume":"7","author":"Westra","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2025121402530570000_12.4.e054202.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.10.035"},{"key":"2025121402530570000_12.4.e054202.15","doi-asserted-by":"crossref","unstructured":"Pellicano M , Lavi I , De Bruyne B . Validation study of image-based fractional flow reserve during coronary angiography10(9). Circulation 2017;10.doi:10.1161\/CIRCINTERVENTIONS.116.005259","DOI":"10.1161\/CIRCINTERVENTIONS.116.005259"},{"key":"2025121402530570000_12.4.e054202.16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/CIRCULATIONAHA.118.037350","article-title":"Accuracy of fractional flow reserve derived from coronary angiography","volume":"139","author":"Fearon","year":"2019","journal-title":"Circulation"},{"key":"2025121402530570000_12.4.e054202.17","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.66.5.930"},{"key":"2025121402530570000_12.4.e054202.18","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV8I12A219"},{"key":"2025121402530570000_12.4.e054202.19","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.21872"},{"key":"2025121402530570000_12.4.e054202.20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.685313"},{"key":"2025121402530570000_12.4.e054202.21","article-title":"Clinical trial update II: TRITON-TIMI 38 provides reassurance on concomitant use of proton pump inhibitors and thienopyridines","volume":"30","year":"2009","journal-title":"Eur Heart J"},{"key":"2025121402530570000_12.4.e054202.22","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004296","article-title":"Impact of Routine Fractional Flow Reserve on Management Decision and 1-Year Clinical Outcome of Patients With Acute Coronary Syndromes: PRIME-FFR (Insights From the POST-IT [Portuguese Study on the Evaluation of FFR-Guided Treatment of Coronary Disease] and R3F [French FFR Registry] Integrated Multicenter Registries - Implementation of FFR [Fractional Flow Reserve] in Routine Practice)","volume":"10","author":"Van Belle","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"2025121402530570000_12.4.e054202.23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.015156"},{"key":"2025121402530570000_12.4.e054202.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.12.025"},{"key":"2025121402530570000_12.4.e054202.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.09.043"},{"key":"2025121402530570000_12.4.e054202.26","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.006368","article-title":"Six-Year follow-up of fractional flow reserve-guided versus angiography-guided coronary artery bypass graft surgery","volume":"11","author":"Fournier","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"2025121402530570000_12.4.e054202.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2007.01.027"},{"key":"2025121402530570000_12.4.e054202.28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.015549"},{"key":"2025121402530570000_12.4.e054202.29","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.004191","article-title":"Design and rationale of the RIPCORD 2 trial (does routine pressure wire assessment influence management strategy at coronary angiography for diagnosis of chest pain?): a randomized controlled trial to compare routine pressure wire assessment with conventional angiography in the management of patients with coronary artery disease","volume":"11","author":"Elguindy","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2025121402530570000_12.4.e054202.30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.114.001608"},{"key":"2025121402530570000_12.4.e054202.31","article-title":"Vessel fractional flow reserve (vFFR) for the assessment of stenosis severity: the fast II study","author":"Masdjedi","year":"2021","journal-title":"EuroIntervention"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-054202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T10:53:13Z","timestamp":1765709593000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-054202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4,4]]},"published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1136\/bmjopen-2021-054202"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-054202","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}